Trump Says New Drug Pricing Policy Could Cut Prescription Costs Dramatically

Donald Trump says his administration is making progress on lowering prescription drug costs, arguing that Americans have long paid significantly higher prices than consumers in other countries for the same medications. Speaking about healthcare costs, Trump pointed to the administration's "Most Favored Nation" pricing approach and claimed it is already helping drive down prescription drug prices. TOP STORY: TRUMP TOUTS LOWER DRUG PRICES According to Trump: “We're delivering record-setting discounts on prescription drugs.” Trump claimed: ➡️ Nearly 1,000 additional low-cost generic drugs have been added to a federal pricing website ➡️ Americans are beginning to see lower prescription costs ➡️ The administration is targeting large international pricing disparities According to Trump: “We have drugs down 400%, 500%, 600%.” Trump argued those figures reflect the large differences that previously existed between U.S. drug prices and prices paid overseas. COMPARING U.S. PRICES TO OTHER COUNTRIES Trump said Americans often paid substantially more for the same medications than consumers in Europe. According to Trump: “A pill that would sell in Germany or London for $10 was selling here for $130.” The administration argues: ➡️ Foreign governments negotiate lower drug prices ➡️ U.S. consumers have historically subsidized pharmaceutical research and development ➡️ International price differences have unfairly burdened American patients “MOST FAVORED NATION” APPROACH Trump also highlighted his administration's "Most Favored Nation" pricing model. Under that concept: ➡️ The United States seeks pricing comparable to the lowest prices paid by other developed countries ➡️ Pharmaceutical companies face pressure to reduce costs ➡️ Federal officials aim to increase affordability for consumers According to Trump: “Every single country agreed and every drug company agreed.” Trump also claimed tariff pressure helped bring parties to the negotiating table. HEALTHCARE COSTS REMAIN A MAJOR ISSUE Supporters argue: ➡️ Lower prescription prices could save patients billions ➡️ Seniors and those with chronic illnesses could benefit significantly ➡️ Greater price transparency is needed throughout the healthcare system Critics argue: ➡️ Pharmaceutical pricing remains highly complex ➡️ International pricing systems operate differently than the U.S. market ➡️ Long-term impacts on innovation and drug development remain debated Prescription drug affordability continues to be one of the most significant healthcare issues facing American consumers. WHY THIS MATTERS This impacts: Prescription drug costs Medicare spending Healthcare affordability Pharmaceutical companies Seniors and patients Federal healthcare policy Drug pricing remains a major political and economic issue as policymakers continue debating how to reduce costs while maintaining access to new treatments. #Trump #PrescriptionDrugs #Healthcare #DrugPrices #Medicare #Politics #HealthPolicy #BreakingNews #Economy #USNews